The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers

Add time:09/01/2019    Source:sciencedirect.com

Estrogen (E2) plays a central role in the development and progression of hormone-responsive cancers. Estrogen metabolites exhibit either stimulatory or inhibitory roles on breast and prostate cells. The catechol metabolite 4-hydroxyestradiol (4-OHE2) enhances cell proliferation, while 2-methoxyestradiol (2 ME) possesses anticancer activity. The major metabolizing enzyme responsible for detoxifying the deleterious metabolite 4-OHE2 and forming the anticancer metabolite 2 ME is Catechol-O-Methyl Transferase (COMT). The current work investigated the relationship between the expression level of COMT and the cell proliferation of hormone-responsive cancers. The results showed that COMT silencing enhanced the cell proliferation of ER-α positive cancer cells MCF-7 and PC-3 but not the cells that lack ER-α expression as MDA-MB231 and DU-145. The data generated from our study provides a better understanding of the effect of COMT on critical signaling pathways involved in the development and progression of breast cancer (BC) and prostate cancer (PC) including ER-α, p21cip1, p27kip1, NF-κB (P65) and CYP19A1. These findings suggest that COMT enzyme plays a tumor suppressor role in hormone receptor-positive tumors which opens the door for future studies to validate COMT expression as a novel biomarker for the prediction of cancer aggressiveness and treatment efficacy.

We also recommend Trading Suppliers and Manufacturers of 2'-(O-METHYL)-5-METHYLCYTIDINE (cas 113886-70-7). Pls Click Website Link as below: cas 113886-70-7 suppliers

Prev:Short communicationCarbonato- and methanediolato(-2)-bridged nickel(II) coordination clusters from the use of N-salicylidene-4-methyl-o-aminophenol☆
Next:Regio- and stereoselective syntheses of l-pentose derivatives from l-arabinose)